Drug Trial Radar · NCT05504395
A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
Last checked: Nov 19, 2026Latest source record: Aug 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Nov 14, 2022
Primary completion
Feb 21, 2023
Study completion Feb 21, 2023
Sponsor
- Lead sponsor
- ConSynance TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Aug 17, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 13 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase 1 study is to evaluate the pharmacokinetics (PK) and safety of a single dose of CSTI-500 10 mg in subjects with Prader-Willi syndrome (PWS) between 13 and 50 years of age with a genetically confirmed diagnosis of PWS.
Conditions
- Prader-Willi Syndrome
Interventions
CSTI-500Drug
Single 10 mg capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Observed Plasma Concentration (Cmax)Time frame: Pre-dose to 1, 2, 4, 8, 12, 24, 48, 72, and 144 hours post-dose
- AUC0-72Time frame: Pre-dose to 1, 2, 4, 8, 12, 24, 48, and 72 hours post-dose
- AUC0-infTime frame: Pre-dose to 1, 2, 4, 8, 12, 24, 48, 72, and 144 hours post-dose
- CSTI-500 plasma concentrationTime frame: 1 hour post-dose
- CSTI-500 plasma concentrationTime frame: 2 hour post-dose
- CSTI-500 plasma concentrationTime frame: 4 hour post-dose
- CSTI-500 plasma concentrationTime frame: 8 hour post-dose
- CSTI-500 plasma concentrationTime frame: 12 hour post-dose
- CSTI-500 plasma concentrationTime frame: 24 hour post-dose
- CSTI-500 plasma concentrationTime frame: 48 hour post-dose
- CSTI-500 plasma concentrationTime frame: 72 hour post-dose
- CSTI-500 plasma concentrationTime frame: 144 hour post-dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vanderbilt University Medical Center
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.